Steffen Walter

Chief Operating Officer at Immatics

Steffen Walter, Ph.D., is the Chief Operating Officer at Immatics, a biotechnology company focused on developing innovative cancer immunotherapies. He has been in this role since March 21, 2023, after previously holding several key positions within the organization, including Chief Technology Officer and Chief Scientific Officer.1 2

Professional Background

Career at Immatics: Steffen joined Immatics in 2005 and has played a pivotal role in the company's growth and development. He was instrumental in establishing Immatics' U.S. operations in Houston, Texas, and has contributed significantly to fundraising efforts, including securing a $20 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT).2 4
Leadership Roles: In his current capacity as COO, he oversees various critical functions such as cell therapy manufacturing, process development, global quality assurance, and human resources. He also leads the construction of new facilities for laboratory and manufacturing operations.2 4

Educational Background

Steffen Walter holds a diploma in biochemistry and a Ph.D. in immunology from the University of Tübingen in Germany. His academic background supports his extensive work in cancer immunotherapy and T-cell biology.2 4

Contributions and Achievements

Patents and Publications: Dr. Walter is an inventor on numerous patents related to his work in immunotherapy and has co-authored over 30 publications in respected peer-reviewed journals such as Nature Medicine and Lancet Oncology .2 4
Technological Development: He has been involved in developing Immatics' XPRESIDENT® technology platform, which aids in identifying tumor-associated peptides for T-cell recognition.3 4

Steffen Walter's extensive experience and leadership at Immatics underscore his significant contributions to advancing cancer treatment through innovative therapies.